SuperworthScilex market cap SCLX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $20M
- Highest close in our data
- $2B
- Apr 2023
Scilex is worth $20M at the close on Oct 23, 2026, at $2.35 a share.
That is down 82% over the last year and down 88% over five years.
Its highest close in our data was $2B in Apr 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $20M | $20M | $99.3M | −81% |
| 2025 | $107M | $27.9M | $203.2M | +43% |
| 2024 | $74.8M | $74.8M | $351.5M | −76% |
| 2023 | $318.1M | $66.3M | $2B | +505% |
| 2022 | $52.6M | $42.8M | $178.1M | −70% |
| 2021 | $173.2M | $170.6M | $292.8M | n/a |
Against its peers
Companies in Healthcare nearest Scilex's size, closest first, today.
| Company | Market cap |
|---|---|
| SCLXScilex | $20M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Scilex
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.